NEXSPIKE is Moderna’s third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and ...

Revenue -- $1.9 billion reported for the quarter, compared to prior sales cycles impacted by earlier U.S. COVID-19 vaccine ...

You recently posted a couple of articles about the respiratory syncytial virus (RSV) vaccine and the benefits versus the ...

The recommendation by the CHMP should now result in approval of Arexvy in the broader age range in February next year, and ...

There is underreporting of adverse effects from vaccines; but, in the vast majority of cases, the side effects from the ...

GSK said on Friday a panel ‍of the European Medicines Agency had backed the use of its ‌respiratory syncytial ‌virus (RSV) ...

Most patients don’t report expected side effects from vaccines, and even when they do, a minority of providers will make a ...

Research led by the Veterans Affairs Portland Health Care System in Portland, Oregon, found that a single dose of respiratory ...

You recently posted a couple of articles about the respiratory syncytial virus (RSV) vaccine and the benefits versus ...

The Food and Drug Administration is investigating whether coronavirus vaccines are linked to deaths of adults, part of an ...

Preliminary Data Shows Platform Generated Over $1.36 Million in Just 14 Days; Daily Revenue Velocity Accelerating Rapidly ...